Hsp27 expression in invasive ductal breast carcinoma

Folia Histochemica et Cytobiologica

Volumn 50, Issue 4, 2012, Pages 527-533

  Grzegrzolka, Jedrzej ^a   Kurnol, Krzysztof ^a   Piotrow, Pawel ^a   Pula, Bartosz ^a   Kobierzycki, Christopher ^a   Piotrowska, Aleksandra ^a   Jablonska, Karolina ^a   Wojnar, Andrzej ^b   Rys, Janusz ^c   Dziegiel, Piotr ^a,d,e   Podhorska Okolow, Marzena ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e UNIVERSITY OF WROC AW   (Poland)

Author keywords

Breast cancer; Heat shock protein; Hsp27

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 27; PROGESTERONE RECEPTOR; HSPB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOTINYLATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EVENT FREE SURVIVAL; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MASTECTOMY; MYOFIBROBLAST; PATHOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; TUMOR INVASION;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2;

EID: 84871817833     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0074     Document Type: Article

References (42)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581-592.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
3. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999;11:1-12.
4. Morimoto RI, Kline MP, Bimston DN, Cotto JJ. The heatshock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 1997;32:17-29.
5. Golenhofen N, Perng MD, Quinlan RA, Drenckhahn D. Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle. Histochem Cell Biol. 2004;122:415-425.
6. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000;92:1564-1572.
7. Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis. 2003;8:61-70.
8. Parcellier A, Schmitt E, Gurbuxani et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol. 2003;23:5790-5802.
9. Arrigo AP. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem. 1998;379:19-26.
10. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10:86-103.
11. Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression. Chin Med J. 2008;121:1975-1979.
12. Aldrian S, Kindas-Mugge I, Trautinger F et al. Overexpression of Hsp27 in a Human Melanoma Cell Line: Regulation of E-Cadherin, MUC18/MCAM, and Plasminogen Activator (PA) System. Cell Stress & Chaperones. 2003;8:249-257.
13. Gomulkiewicz A, Podhorska-Okolow M, Szulc R. Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. Folia Histochem Cytobiol. 2010;48:242-248.
14. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive Score (IRS) for immunohistochemicalestrogen receptor detection (ER-ICA) in breast cancer. Pathologe. 1987;8:138-140.
15. Wolff AC, Hammond ME, Schwartz JN et al. Wheeler TM and Hayes DF; American Society of Clinical Oncology/College of American Pathologists: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43.
16. Ciocca DR, Stati AO, Amprino de Castro MM. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue. Breast Cancer Res Treat. 1990;16:243-251.
17. Muńoz de Toro MM, Luque EH. Lack of relationship between the expression of hsp27 heat shock estrogen receptorassociated protein and estrogen receptor or progesterone receptor status in male breast carcinoma. J Steroid Bioc Mol Biol. 1997;60:277-284.
18. Vargas-Roig LM, Fanelli MA, López LA et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev. 1997;21:441-451.
19. Ciocca DR, Puy LA, Edwards DP, Adams DJ, McGuire WL. The presence of an estrogen-regulated protein detected by monoclonal antibody in abnormal human endometrium. J Clin Endocrinol Metab. 1985;60:137-143.
20. Ciocca DR, Puy LA, Fasoli LC. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Cancer Res. 1989;49:4298-4304.
21. Navarro D, Cabrera JJ, León L, Chirino R et al. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J Steroid Biochem Mol Biol. 1992;41:589-596.
22. Langdon SP, Rabiasz GJ, Hirst GL et al. Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res. 1995;1:1603-1609.
23. Małusecka E, Zborek A, Krzyzowska-Gruca S, Krawczyk Z. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study. Anticancer Res. 2001;21:1015-1021.
24. Missotten GS, Journée-de Korver JG, de Wolff-Rouendaal D, Keunen JE, Schlingemann RO, Jager MJ. Heat shock protein expression in the eye and in uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:3059-3065.
25. Oesterreich S, Hilsenbeck SG, Ciocca DR et al. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin Cancer Res. 1996;2:1199-1206.
26. Love S, King RJ. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J Cancer. 1994;69:743-748.
27. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis I. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study. Anticancer Res. 1997;17:2677-2682.
28. Khalid H, Tsutsumi K, Yamashita H, Kishikawa M, Yasunaga A, Shibata S. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Cell Mol Neurobiol. 1995;15:257-268.
29. King KL, Li AF, Chau GY et al. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer. 2000;88:2464-2470.
30. Ito T, Kawabe R, Kurasono Y, Hara M, Kitamura H, Fujita K, Kanisawa M. Expression of heat shock proteins in squamous cell carcinoma of the tongue: an immunohistochemical study. J Oral Pathol Med. 1998;27:18-22.
31. Kawanishi K, Shiozaki H, Doki Y et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer. 1999;85:1649-1657.
32. Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G, Theocharis SE. Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol. 2009;9:14.
33. Ciocca DR, Luque EH. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Treat. 1991;20:33-42.
34. Coffer AI, King RJ. Characterization of p29, an estrogenreceptor associated tumor marker. J Steroid Biochem. 1988;31:745-750.
35. Takahashi S, Narimatsu E, Asanuma H et al. Immunohistochemical detection of estrogen receptor in invasive human breast cancer: correlation with heat shock proteins, pS2 and oncogene products. Oncology. 1995;52:371-375.
36. Ioachim E, Tsanou E, Briasoulis E et al. Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer. Breast. 2003;12:111-119.
37. Mlynarczyk-Liszka J, Maksymiuk B, Ponikiewska D. HSP27 diagnostic utility in the fine needle aspirate of breast. Correlation with progesterone and estrogen receptors. Neoplasma. 2009;56:357-360.
38. Hurlimann J, Gebhard S, Gomez F. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology. 1993;23:239-248.
39. Liebhardt S, Ditsch N, Nieuwland R et al. CEA-, Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients. Anticancer Res. 2010;30:1707-1712.
40. Meng L, Gabai VL, Sherman MY. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene. 2010;29:5204-5213.
41. Kang SH, Kang KW, Kim KH et al. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer. 2008;8:286.
42. Cardoso F, Di Leo A, Larsimont D et al. Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes. Ann Oncol. 2001;12:615-620.